ID: ALA3953131

Max Phase: Preclinical

Molecular Formula: C15H19NO5S2

Molecular Weight: 357.45

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCCNC(=O)c1ccc(C2=CS(=O)(=O)CCCS2(=O)=O)cc1

Standard InChI:  InChI=1S/C15H19NO5S2/c1-2-8-16-15(17)13-6-4-12(5-7-13)14-11-22(18,19)9-3-10-23(14,20)21/h4-7,11H,2-3,8-10H2,1H3,(H,16,17)

Standard InChI Key:  COXZJCVTYQYWAT-UHFFFAOYSA-N

Associated Targets(Human)

Galanin receptor 1 253 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 357.45Molecular Weight (Monoisotopic): 357.0705AlogP: 1.36#Rotatable Bonds: 4
Polar Surface Area: 97.38Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: -0.43CX LogD: -0.43
Aromatic Rings: 1Heavy Atoms: 23QED Weighted: 0.88Np Likeness Score: -0.84

References

1.  (2002)  1,4-dithiin and 1,4-dithiepin-1,1,4,4, tetroxide derivatives useful as antagonists of the human galanin receptor, 

Source